Abstract
Delta9-tetrahydrocannabinol (THC) impairs multiple immunological functions. The ability of a macrophage hybridoma to function as an antigen-presenting cell was examined by the stimulation of a soluble protein antigen-specific helper T cell hybridoma to secrete interleukin-2. THC exposure significantly reduced the T cell response to the native form of the antigen after a 24-h pretreatment of the macrophages with nanomolar drug concentrations. However, THC did not affect interleukin-2 production when the macrophages presented a synthetic peptide of the antigen to the T cells, suggesting that the drug may interfere with antigen processing, not peptide presentation. Cannabinoid inhibition of the T cell response to the native antigen was stereoselective consistent with the involvement of a cannabinoid (CB) receptor. Bioactive CP-55,940 diminished T cell activation, whereas the inactive stereoisomer CP-56,667 did not. The macrophage hybridoma expressed mRNA for the CB2 but not the CB1 receptor whereas the T cells expressed an extremely low level of mRNA for the CB2 receptor. The CB1-selective antagonist SR141716A did not reverse the suppression caused by THC, demonstrating that the CB1 receptor was not responsible for the drug’s inhibitory effect. In contrast, the CB2-selective antagonist SR144528 completely blocked THC’s suppression of the T cell response, implicating the participation of the CB2 receptor. These findings suggest that the CB2 receptor may be involved in CB inhibition of antigen processing by macrophages in this system.
Footnotes
-
Send reprint requests to: Dr. Kathleen L. McCoy, Department of Microbiology and Immunology, MCV Station, Box 980678, Virginia Commonwealth University, Richmond, VA 23298-0678. E-mail:kmccoy{at}hsc.vcu.edu
-
↵1 This work was supported by National Institutes of Health Grants DA05832, P50 DA05274, and ES07199. Dr. Carlisle was supported in part by National Institutes of Health Grant T32 DA07027.
- Abbreviations:
- CB
- cannabinoid
- CB1
- cannabinoid receptor 1
- CB2 cannabinoid receptor 2
- HEL, hen egg lysozyme
- IL-2
- interleukin-2
- MHC
- major histocompatibility complex
- MRT-PCR
- mutagenic reverse transcription-polymerase chain reaction
- PCR
- polymerase chain reaction
- RT
- reverse transcription
- THC
- delta9-tetrahydrocannabinol
- Received September 30, 1998.
- Accepted February 22, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|